share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  05/02 10:08
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,484.3, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of $283,672.35. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares on 05/02/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $3,484.3, were originally acquired on 10/07/2022 as part of a restricted stock vesting agreement with the issuer, serving as compensation for Austin. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of $283,672.35. The notice for the planned sale was filed on the same day as the sale, with the plan for this transaction having been adopted on 03/14/2023.
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年2月5日出售3,968股A类股票。这些股票的总市值为3,484.3美元,最初是在2022年7月10日作为与发行人签订的限制性股票归属协议的一部分收购的,作为对奥斯汀的补偿。这笔即将进行的交易是在过去三个月进行了一系列销售之后进行的,共出售了246,016股股票,总收益为283,672.35美元。计划出售的通知是在出售的同一天提交的,该交易的计划已于2023年3月14日获得通过。
正如在最近的一份文件中宣布的那样,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年2月5日出售3,968股A类股票。这些股票的总市值为3,484.3美元,最初是在2022年7月10日作为与发行人签订的限制性股票归属协议的一部分收购的,作为对奥斯汀的补偿。这笔即将进行的交易是在过去三个月进行了一系列销售之后进行的,共出售了246,016股股票,总收益为283,672.35美元。计划出售的通知是在出售的同一天提交的,该交易的计划已于2023年3月14日获得通过。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息